Taro Pharmaceutical Industries Ltd. (TARO) Reports Q4 EPS of $2.10

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) reported Q4 EPS of $2.10, versus $1.10 reported last year. Revenue for the quarter came in at $187.2 million, versus $165.13 million reported last year.

For earnings history and earnings-related data on Taro Pharmaceutical Industries Ltd. (TARO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Diana Shipping withdraws bid to acquire Genco Shipping